Search research articles
Contact Us
Filters
Showing results (41-50 of 105) with videos related to
Page
of 11
Sort By:
Rinsho Byori. the Japanese Journal of Clinical Pathology
|
December 1, 1988
[Androgen-dependent carcinoma]
J Shimazaki, H Fuse, S Akimoto, et al.
Hinyokika Kiyo. Acta Urologica Japonica
|
July 1, 1990
[Changes in prostatic acid phosphatase, gamma-seminoprotein and prostate specific antigen after endocrine therapy for stage D2 prostate cancer]
S Akimoto, K Akakura, M Masai, et al.
Anticancer Research
|
May 16, 2000
Changes in cell proliferation and apoptosis during local progression of prostate cancer
T Kaibuchi, Y Furuya, K Akakura, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1994
Chemotherapy for endocrine-therapy-refractory prostate cancer
S Akimoto, T Ohki, K Akakura, et al.
Cancer
|
September 1, 1993
Luteinizing hormone-releasing hormone agonists in prostate cancer. Elimination of flare reaction by pretreatment with cyproterone acetate and low-dose diethylstilbestrol
N Bruchovsky, S L Goldenberg, K Akakura, et al.
Endocrinologia Japonica
|
April 1, 1988
Partial purification of androgen receptor from hypertrophic human prostate
T Kodama, K Akakura, R Kato, et al.
Japanese Journal of Clinical Oncology
|
August 1, 1997
Prognostic factors in patients with prostate cancer refractory to endocrine therapy: univariate and multivariate analyses including doubling times of prostate-specific antigen and prostatic acid phosphatase
S Akimoto, H Inomiya, K Akakura, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
June 22, 1999
Pattern of progression and survival in hormonally treated metastatic prostate cancer
Y Furuya, K Akakura, S Akimoto, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
March 1, 1995
Disease progression in stage A prostate cancer
M Amakasu, S Akimoto, K Akakura, et al.
European Urology
|
August 7, 1998
Prognostic value of the serum levels of bone formation and bone resorption markers in prostate cancer patients with bone metastasis
S Akimoto, H Inomiya, Y Furuya, et al.
Page
of 11
Search research articles
Search
Showing results (41-50 of 105) with videos related to
Sort By:
Page
of 11
Rinsho Byori. the Japanese Journal of Clinical Pathology
|
December 1, 1988
[Androgen-dependent carcinoma]
J Shimazaki, H Fuse, S Akimoto, et al.
Hinyokika Kiyo. Acta Urologica Japonica
|
July 1, 1990
[Changes in prostatic acid phosphatase, gamma-seminoprotein and prostate specific antigen after endocrine therapy for stage D2 prostate cancer]
S Akimoto, K Akakura, M Masai, et al.
Anticancer Research
|
May 16, 2000
Changes in cell proliferation and apoptosis during local progression of prostate cancer
T Kaibuchi, Y Furuya, K Akakura, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1994
Chemotherapy for endocrine-therapy-refractory prostate cancer
S Akimoto, T Ohki, K Akakura, et al.
Cancer
|
September 1, 1993
Luteinizing hormone-releasing hormone agonists in prostate cancer. Elimination of flare reaction by pretreatment with cyproterone acetate and low-dose diethylstilbestrol
N Bruchovsky, S L Goldenberg, K Akakura, et al.
Endocrinologia Japonica
|
April 1, 1988
Partial purification of androgen receptor from hypertrophic human prostate
T Kodama, K Akakura, R Kato, et al.
Japanese Journal of Clinical Oncology
|
August 1, 1997
Prognostic factors in patients with prostate cancer refractory to endocrine therapy: univariate and multivariate analyses including doubling times of prostate-specific antigen and prostatic acid phosphatase
S Akimoto, H Inomiya, K Akakura, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
June 22, 1999
Pattern of progression and survival in hormonally treated metastatic prostate cancer
Y Furuya, K Akakura, S Akimoto, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
March 1, 1995
Disease progression in stage A prostate cancer
M Amakasu, S Akimoto, K Akakura, et al.
European Urology
|
August 7, 1998
Prognostic value of the serum levels of bone formation and bone resorption markers in prostate cancer patients with bone metastasis
S Akimoto, H Inomiya, Y Furuya, et al.
Page
of 11